[ad_1] The United States has approved the Swiss pharmaceutical company Novartis a genetical therapy which treats a rare childhood disorder that atrophies the motor capacity of babies and that usually causes death …
Read More »[ad_1] The United States has approved the Swiss pharmaceutical company Novartis a genetical therapy which treats a rare childhood disorder that atrophies the motor capacity of babies and that usually causes death …
Read More »